Trilogy Capital’s Danaher DHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,466
Closed -$278K 411
2026
Q1
$278K Buy
1,466
+8
+0.5% +$1.7K 0.01% 335
2025
Q4
$334K Sell
1,458
-17
-1% -$3.74K 0.01% 299
2025
Q3
$292K Buy
1,475
+9
+0.6% +$1.79K 0.01% 314
2025
Q2
$290K Sell
1,466
-1
-0.1% -$194 0.01% 299
2025
Q1
$301K Sell
1,467
-21
-1% -$4.58K 0.02% 282
2024
Q4
$342K Buy
1,488
+8
+0.5% +$1.97K 0.02% 267
2024
Q3
$411K Sell
1,480
-19
-1% -$5.03K 0.02% 244
2024
Q2
$375K Buy
+1,499
New +$379K 0.02% 242
2018
Q4
Sell
-9
Closed -$1K 237
2018
Q3
$1K Hold
9
﹤0.01% 551
2018
Q2
$1K Buy
+9
New +$802 ﹤0.01% 512

Other funds holding DHR

Trilogy Capital's DHR Position: Q2 2026 in Review

Trilogy Capital sold out of Danaher (DHR) in Q2 2026, closing a stake of 1,466 shares — an estimated $278K sold.

Trilogy Capital first reported a position in DHR in Q2 2018 and held it in 10 quarters. The position peaked at $411K in Q3 2024. 331 funds tracked by Wall St. Rank hold DHR as of Q2 2026.

  • Trilogy Capital reported no remaining Danaher position as of Q2 2026 after selling out during the quarter.
  • Trilogy Capital sold 1,466 Danaher shares in Q2 2026, an estimated $278K.
  • Trilogy Capital first reported a position in Danaher in Q2 2018 and held it in 10 quarters.
  • Trilogy Capital's Danaher position peaked at $411K in Q3 2024.
  • 331 funds tracked by Wall St. Rank held Danaher as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.